OLIMEL N9E, émulsion pour perfusion

Baxter

Marketing Authorization Holder · Finished Dosage FormsUnited States

Basic Information

Documents

Drug Marketing Authorization Number

Document No.: 66032721

Issue Date: Jul 21, 2008

Ratings

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Explore More

Similar Products & Services

Products & Services related to what you're viewing

Explore More

People Also Viewed

Other products & services viewed by people who looked at this product

Discover More

Packaging: 6 pouches at 3 compartiments polypropylene polyethylene SEBS : styrene-ethylene-butylene-styrene EVA : ethylene vinyl acetate copolymer PCCE poly(cyclohexylène dimethylène) cyclohexane dicarboxylate/tetramethyl glycol overwrapped(s)/overpouched(s) of • 4 pouches at 3 compartiments polypropylene polyethylene SEBS : styrene-ethylene-butylene-styrene EVA : ethylene vinyl acetate copolymer PCCE poly(cyclohexylène dimethylène) cyclohexane dicarboxylate/tetramethyl glycol overwrapped(s)/overpouched(s) of • 4 pouches at 3 compartiments polypropylene polyethylene SEBS : styrene-ethylene-butylene-styrene EVA : ethylene vinyl acetate copolymer PCCE poly(cyclohexylène dimethylène) cyclohexane dicarboxylate/tetramethyl glycol overwrapped(s)/overpouched(s) of